Oncology Assay Development
Cancer Diagnostics
ResearchActive
Key Facts
About Transformative Biotech
Transformative Biotech is a private, early-revenue-stage company commercializing a foundational, extraction-free PCR chemistry platform. Its core innovation removes the pre-analytical bottleneck of traditional PCR, enabling faster, simpler, and more affordable molecular testing directly from samples. With an issued patent, significant real-world validation through a partner lab, and a seasoned leadership team, the company is positioned as an enabler for next-generation diagnostics, targeting partnerships with instrument and assay developers to expand access to PCR testing.
View full company profileTherapeutic Areas
Other Cancer Diagnostics Drugs
| Drug | Company | Phase |
|---|---|---|
| Isabl for Oncology | Isabi | Unknown |
| 3D AI Cancer Dx Platform (w/ PathNet) | Alpenglow Biosciences | Development |
| Aperio Digital Pathology Ecosystem | Leica Biosystems | Commercial & Development |
| Cell Separation for Liquid Biopsy | SynderBio | Pre-clinical |
| TelomeScan (OBP-401, OBP-1101) | Oncolys BioPharma | Diagnostic |